Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2174/1389557520666201124141103 http://scihub22266oqcxt.onion/10.2174/1389557520666201124141103 33234101!?!33234101 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33234101&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Mini+Rev+Med+Chem 2021 ; 21 (8): 952-968 Nephropedia Template TP {{tp|p=33234101|t=2021. Recent Approaches of Repositioning and Traditional Drugs for the Treatment of COVID-19 Pandemic Outbreak |pdf=|usr=}}{{33234101}} gab.com Text Recent Approaches of Repositioning and Traditional Drugs for the Treatment of COVID-19 Pandemic Outbreak JO: Mini Rev Med Chem http://www.kidney.de/pget.php?&tw=1&pmid=33234101 #FOAvip The recent emergence of novel, pathogenic COVID-19 disease associated with SARSCoV- 2 virus in China and its rapid national and international spread pose a global health emergency. The development of a new drug is tedious and may take decades to develop and involve multiple steps like the development of prototypes and phase I to III human trials, which involve the study on small to large populations to examine the safety and side effects associated with the drug under trials. Due to continous increase in the number of confirmed cases and deaths, there is an urgent need to develop a drug that is effective to kill the SARS-CoV-2 virus with fewer side effects to the human body. Therefore, this review focus on the latest advances in the development for the treatment of COVID-19 disease associated with SARS-CoV-2 with repositioning of already marketed drug with small molecules, as well as Chinese traditional medicines with established safety and efficacy which are being used for different therapeutic uses. Twit Text FOAVip Recent Approaches of Repositioning and Traditional Drugs for the Treatment of COVID-19 Pandemic Outbreak ????Mini Rev Med Chem http://www.kidney.de/pget.php?&tw=1&pmid=33234101 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33234101 #FOAvip English Wikipedia <ref>{{Cite pmid|33234101}}</ref> Recent Approaches of Repositioning and Traditional Drugs for the Treatment of COVID-19 Pandemic Outbreak #MMPMID33234101 Tandon N; Luxami V; Tandon R; Paul K Mini Rev Med Chem 2021[]; 21 (8): 952-968 PMID33234101show ga The recent emergence of novel, pathogenic COVID-19 disease associated with SARSCoV- 2 virus in China and its rapid national and international spread pose a global health emergency. The development of a new drug is tedious and may take decades to develop and involve multiple steps like the development of prototypes and phase I to III human trials, which involve the study on small to large populations to examine the safety and side effects associated with the drug under trials. Due to continous increase in the number of confirmed cases and deaths, there is an urgent need to develop a drug that is effective to kill the SARS-CoV-2 virus with fewer side effects to the human body. Therefore, this review focus on the latest advances in the development for the treatment of COVID-19 disease associated with SARS-CoV-2 with repositioning of already marketed drug with small molecules, as well as Chinese traditional medicines with established safety and efficacy which are being used for different therapeutic uses. |*COVID-19 Drug Treatment[MESH] |*Disease Outbreaks[MESH] |*Drug Repositioning[MESH] |*Pandemics[MESH] |Antiviral Agents/pharmacology/*therapeutic use[MESH] |COVID-19/epidemiology/virology[MESH] |Humans[MESH]Recent Approaches of Repositioning and Traditional Drugs for the Treat(epmc).pdf DeepDyve Pubget Overpricing